CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for 12 weeks, to reduce key markers of inflammation related to CVD risk, such as IL-6 and IL-18, in approximately 24 people with known heart ...
Phase 2
Tacoma, Washington, United States and 4 other locations
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Seattle, Washington, United States and 27 other locations
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...
Seattle, Washington, United States and 13 other locations
native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open ...
Seattle, Washington, United States and 8 other locations
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have tr...
Seattle, Washington, United States and 11 other locations
open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart...
Seattle, Washington, United States and 74 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Everett, Washington, United States and 62 other locations
To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic...
Seattle, Washington, United States and 29 other locations
This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with c...
Seattle, Washington, United States and 76 other locations
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Seattle, Washington, United States and 84 other locations
Clinical trials
Research sites
Resources
Legal